The National Times - Stocks stabilise after Wall St AI-fuelled sell-off

Stocks stabilise after Wall St AI-fuelled sell-off


Stocks stabilise after Wall St AI-fuelled sell-off

Stock markets stabilised Wednesday following a tech-led selloff spurred by AI disruption fears, while precious metals recovered further.

Change text size:

Both the Dow and the S&P 500 advanced as trading got underway in New York, although the Nasdaq Composite dipped amid continuing concern about the impact of AI.

European and Asian markets were mostly higher.

"The dust settled on Wednesday after a dramatic session for tech-related stocks amid new AI disruption," said Dan Coatsworth, head of markets at AJ Bell.

Nevertheless investors were still shifting out of tech stocks.

"We're seeing a lot of rotation from growth stocks to value stocks, moving from tech into other sectors, and a lot of dispersion of individual stock results," said Steve Sosnick of Interactive Brokers.

Investors were spooked Tuesday by news that AI startup Anthropic -- which created the Claude chatbot -- had unveiled a tool that could be used by firms to carry out legal work.

The announcement hit firms in the software, financial services and asset management industries, with the tech-heavy Nasdaq Composite ending Tuesday down 1.4 percent.

"Investors fear the AI juggernaut will cut deeply into earnings as agents take over workflows and replace more traditional programmes," said Susannah Streeter, chief investment strategist at Wealth Club.

Downbeat sales projections from Advanced Micro Devices compounded the darker mood, with the company's share price falling 12 percent as trading got underway in New York.

Investors will be looking at earnings reports by Google-parent company Alphabet after the close of trading on Wednesday and Amazon on Thursday for indications about AI investment and revenue.

Massive spending to build data centers to run AI applications helped push equity markets to record highs last year, but recurring concerns that a bubble may be forming have recently prompted volatility.

These concerns were primarily that the hefty investments in AI may never make returns, while Tuesday's selloff hit companies that could see their business activity disrupted by the technology.

Meanwhile, data showed private sector employment in the United States rose by a less-than-expected 22,000 jobs in January.

The "update serves as a reminder that the US remains far from a robust jobs market," said eToro analyst Bret Kentwell.

If the jobs report prepared by the US government, delayed by the shutdown, "shows a similar dynamic, it should at a minimum help keep the Fed from adopting an overly restrictive stance as the first quarter progresses," he added.

The US Federal Reserve last week resisted pressure from the Trump Administration to cut interest rates, saying the US economy is expanding at a solid rate.

Investors expect it may next cut rates in June or July if the weakness in the labour market continues.

In Europe, shares in Danish pharmaceuticals group Novo Nordisk plunged over 17 percent in Copenhagen after the maker of Ozempic and Wegovy anti-obesity drugs warned of lower sales this year.

Official data showed eurozone inflation eased below the European Central Bank's two-percent target in January, with the ECB expected to leave interest rates unchanged on Thursday.

The Bank of England is also expected to hold borrowing costs the same day.

Precious metals rose for a second day, after tanking on Friday and Monday as US President Donald Trump's nomination of hawkish Kevin Warsh to head the Federal Reserve sent the dollar surging.

Gold traded back above $5,000 an ounce after posting its largest daily gain since 2008 on Tuesday.

- Key figures at around 1430 GMT -

New York - Dow: UP 0.4 percent at 49,436.56 points

New York - S&P 500: UP 0.1 percent at 6,925.26

New York - Nasdaq Composite: DOWN 0.1 percent at 23,223.95

London - FTSE 100: UP 1.6 percent at 10,475.54

Paris - CAC 40: UP 0.9 percent at 8,254.08

Frankfurt - DAX: DOWN 0.5 percent at 24,658.71

Tokyo - Nikkei 225: DOWN 0.8 percent at 54,293.36 (close)

Hong Kong - Hang Seng Index: UP 0.1 percent at 26,847.32 (close)

Shanghai - Composite: UP 0.9 percent at 4,102.20 (close)

Euro/dollar: DOWN at $1.1812 from $1.1829 on Tuesday

Pound/dollar: DOWN at $1.3698 from $1.3701

Dollar/yen: DOWN at 156.55 yen from 155.74 yen

Euro/pound: DOWN at 86.23 pence from 86.30 pence

Brent North Sea Crude: UP 0.2 percent at $67.44 per barrel

West Texas Intermediate: UP less than 0.1 percent at $63.27 per barrel

burs-rl/gv

P.Jones--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size: